ImmPACT Bio USA
ImmPACT Bio USA is a startup headquartered in West Hills, United States, founded in 2019. It has raised at least $139.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
ImmPACT Bio USA has raised at least $139.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
ImmPACT Bio USA sits inside the Los Angeles and Southern California R&D ecosystem in the Global R&D Labs Directory.
Related
Questions and answers
What does ImmPACT Bio USA do?
ImmPACT Bio USA is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has ImmPACT Bio USA raised?
At least $139.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is ImmPACT Bio USA based?
ImmPACT Bio USA is headquartered in West Hills, United States.
When was ImmPACT Bio USA founded?
ImmPACT Bio USA was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.